Optical Fiber Bull Stock Clarification: The Company Has No Business Relationship with NVIDIA! | After-Hours Announcement Highlights
Optical fiber stock urgently clarifies no connection with NVIDIA! Stock with five limit-up days in seven trading sessions issues risk warning; pharmaceutical giant announces its holding subsidiary has signed an exclusive option agreement.
Another deal! Hengrui Pharma partners with BMS in strategic collaboration with a potential transaction value of $15.2 billion | Flash Report
① Hengrui and BMS have signed an agreement to jointly advance 13 early-stage projects covering oncology, hematology, and immunology; ② BMS will pay an upfront fee of $600 million and an anniversary payment of $350 million, with milestone payments reaching approximately $15.2 billion. Hengrui is also entitled to receive sales royalties; ③ This represents a two-way licensing collaboration, with Hengrui obtaining the rights to four of BMS's immunology projects in China. The agreement is expected to close in the third quarter of 2026.
Little K Morning Report | Tencent Co-invests in Step's $2.5 Billion Financing; OpenAI Invests Over $4 Billion to Establish New Division
① Investor Michael Burry warned that the Nasdaq 100 Index may experience a significant decline; ② Guangzhou: Supporting the research and development of potential blockbuster smart hardware products such as AI glasses; ③ BeiGene: Net profit for the first quarter was 1.608 billion yuan.
STAR Market Daily: SMIC's $40.6 billion acquisition approved; MicroSpace STAR Market IPO application accepted.
①South Asia New Material plans to raise no more than 900 million yuan for its AI computing power high-end high-frequency and high-speed copper clad laminate project; ②Guoyi Quantum's STAR Market IPO has been approved; ③Tebao Bio plans to repurchase shares worth between 300 million yuan and 500 million yuan; ④BeiGene reported a net profit of 1.608 billion yuan in the first quarter, reversing a year-on-year loss to profitability.
SK Hynix pre-IPO shareholders hold 5 million shares! A 27-billion-yuan memory chip concept stock issues an unusual movement announcement | Post-market announcements highlights
Beijing-Shanghai High-Speed Railway: The published ticket prices for some EMU trains on the Beijing-Shanghai high-speed line and the Hefei-Bengbu high-speed line will increase by 20%.
Low stock prices prompt shareholders to urge share repurchases; Kanghong Pharmaceutical plans to invest over 1 billion yuan annually in R&D in the future | Earnings meeting coverage
①During the earnings call, several participants expressed dissatisfaction with the current stock price of Kanghong Pharmaceutical and suggested that the company take various measures to boost investor confidence; ②Kanghong Pharmaceutical also shared updates on the progress of its highly anticipated R&D pipeline.